CPAP devices for sleep apnoea therapy
If you experience sleep-disordered breathing, there’s probably a ResMed CPAP device that’s right for you.
All of our devices can be paired with a user-friendly coaching app to help you improve your experience and monitor your progress.
Your healthcare team can check your therapy data and offer tailored treatment solutions, either remotely or in person.
CPAP and APAP machines
Experience discreet, effective therapy for your sleep-disordered breathing with ResMed CPAP and AutoSet machines. These obstructive sleep apnoea therapy devices offer performance and comfort features.
Sleep bilevel machines
Our bilevel devices are ideal if you need positive airway pressure therapy but aren’t a suitable candidate for CPAP therapy. Designed with comfort in mind, a bilevel device from ResMed could offer you a good night’s sleep.
Adaptive servo-ventilation**
AirCurve 10 CS PaceWave
Synchronised therapy for central sleep apnoea with and without obstructive sleep apnoea
Can’t find the product you’re looking for?
It might have been discontinued: please contact your ResMed sales representative for information. You can also visit our user guides and technical documents page to explore other resources.
Explore more products
Ventilation machines
Whether your patient needs mechanical ventilation at home, in hospital or on the move, our versatile ventilation devices provide effective therapy for a wide range of respiratory conditions.
Accessories
Browse our selection of replaceable spare parts and device accessories to help ensure your patients’ equipment continues to work optimally.
Masks
ResMed’s sleep apnoea and respiratory care masks are designed to provide comfortable and effective therapy. Learn more about wide range of full face masks, nasal masks and nasal pillows masks.
Please refer to the user guide for relevant information related to any warnings and precautions to be considered before and during use of the product.
References:
* As at 18 March 2021. 136 mm (W) x 84 mm (D) x 52 mm (H), 450 cm³.
** ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.
